← FDA Drug Approvals (Drugs@FDA)

WELIREG

NDA · New Drug Application · Sponsor: MERCK SHARP DOHME · Approved 2021-08-13

Drug application

FDA Application #

NDA215383

Application type

New Drug Application

Brand name

WELIREG

Generic name

BELZUTIFAN

Active ingredients

BELZUTIFAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MERCK SHARP DOHME

Manufacturer

Merck Sharp & Dohme LLC

First approval

2021-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown